Aclaris Therapeutics' Lead Drug Candidate A-101 Achieves Statistically … – Business Wire (press release)
Aclaris Therapeutics' Lead Drug Candidate A-101 Achieves Statistically …Business Wire (press release)In the trial, A-101 demonstrated clinically and statistically significant improvements in removing seborrheic keratosis (SK) lesions on the face. SK is one of the most common types of skin tumors. Although the lesions are … Next steps,” said Stuart D …and more »
Woman covered in severe eczema which caused 'snowstorm' when she walked cured by PORRIDGE
An eczema sufferer whose painful condition covered her entire body causing a "snowstorm" of flaky skin when she walked has found a surprise cure in the cereal aisle.